S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

Pre-Market Stock News (December 5, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

This not all of the big stock news in pre-market trading on Tuesday evening, but these are some of the ones that a673b.bigscoots-temp.com is focusing on.

  • Adolor (NASDAQ:ADLR) in pain treatment collaboration pact with Pfizer.
  • AECOM (NYSE:ACM) announced a $63.6 million DOD contract for support services in Iraq.
  • Blyth Industries (NYSE:BTH) $0.24 EPS vs. $0.12 estimates.
  • Comcast (NASDAQ:CMCSA) down 4% on them cutting cable subscriber growth rates.
  • DSW (NYSE:DSW) beat earnings but guidance is light.
  • Fannie Mae (NYSE:FNM) cut dividend from $0.50 to $0.35; will sell $7 Billion in securities.
  • Goodrich Petroleum (NYSE:GDP) priced 5.8 million shares at $23.50.
  • Guess$ (NYSE:GES) $0.62 EPS vs $0.58 est.; raised 2008 and 2009 guidance.
  • Hercules Offshore (NASDAQ:HERO) announced a 3-year contract for jackup rigs in India.
  • Jones Soda (NASDAQ:JSDA) CEO Van Stolk is stepping down at the end of this year.
  • Lexicon Pharma (NASDAQ:LXRX) starts dosing for Phase IIa Trial with LX6171 for Alzheimer’s Disease.
  • Napster (NASDAQ:NAPS) is launching a new music discovery and listening channel through NTT DoCoMo.
  • Raytheon (NYSE:RTN) up marginally after Jim Cramer called it a permanent bullish stock.
  • Sohu.com (NASDAQ:SOHU) trading up over 10% after raised guidance.
  • Synta Pharma receives (NASDAQ:SNTA) $80 million upfront payment from GlaxoSmithKline.
  • United Therapeutics (NASDAQ:UTHR) said its OvaRex MAb trials failed to meet endpoints on ovarian cancer trials.

Jon C. Ogg
December 5, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Continue Reading

Douglas A. McIntyre |

Pre-Market Stock Notes (FEB 27, 2007)

(ASTE) Astec $0.29 EPS vs $0.26e.(BRCD) Brocade traded up 9% after beating earnings.(BIDU) Baidu.com and other Chinese stocks all trading…
Douglas A. McIntyre |

Pre-Market Stock News (August 16, 2007)

(AMGN) Amgen announced 12-14% layoffs and lowered guidance for 2007.(ANX) ADVENTRX Pharma announces fast track designation granted by the FDA…
Douglas A. McIntyre |

Pre-Market Stock News (MAR 27, 2007)

(AMTD) Ameritrade COO Randy MacDonald will retire on June 1, 2007 following the TD Waterhouse clearing conversion.(AKRX) Akorn signs exclusive…
Douglas A. McIntyre |

Pre-Market Stock News (September 20, 2007)

(ATHN) Athenahealth IPO priced at $18, above the $14 to $16 range.(BCRX) BioCryst Pharma shares down over 30% after flu…
Douglas A. McIntyre |

Pre-Market Stock News (Nov. 20, 2006)

by Jon C. Ogg (AGE) A.G.Edwards announced 10M share buyback.(AGN) Allergan indicated higher as FDA allows Silicone breast implants after…
Douglas A. McIntyre |

Pre-Market Stock News (FEB 26, 2007)

(AXP) American Express’ CFO leaving to be CFO of Citigroup.(BSTE) Biosite noted as a good speculative stock according to Cramer…
Douglas A. McIntyre |

Pre-Market Stock News (October 2, 2007)

(AXL) American Axle traded up after-hours as Cramer said they would benefit from UAW contracts like GM did.(BMC) BMC Software…
Douglas A. McIntyre |

Pre-Market Stock News (MAR 1, 2007)

(ALNY) Alnylam and Isis announce allowance of first U.S. Patent covering human microRNAs.(ALO) Alpharma said the FDA approved its Kadian…
Douglas A. McIntyre |

Pre-Market Stock News (June 12, 2007)

(ACAS) American Capital announced a 17 million stock offering, 12 million of which are from the company and 5 million…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618